Mirtazapine Tablet
Product Images NDC 70518-4548

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-4548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure of mirtazapine, showing the arrangement of nitrogen-containing rings and a methyl group attached to the molecule.*

FDA Label Image

Remedy_label (Remedy Label)

Mirtazapine Tablet 30 mg bottle label includes quantity of 30 tablets. The label displays the NDC number 70518-4548-00, indicates the tablets are brown and oval-shaped, and is marked for prescription use only. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.